טוען...
Hormone Therapy and the Risk of Breast Cancer in BRCA1 Mutation Carriers
BACKGROUND: Hormone therapy (HT) is commonly given to women to alleviate the climacteric symptoms associated with menopause. There is concern that this treatment may increase the risk of breast cancer. The potential association of HT and breast cancer risk is of particular interest to women who carr...
שמור ב:
| Main Authors: | , , , , , , , , , , , , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Oxford University Press
2008
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2556701/ https://ncbi.nlm.nih.gov/pubmed/18812548 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djn313 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|